API
< Back to all clusters
[HEALTH] · Canada, United States, Germany · 2 sources

started · updated

COVID-19 PJ.2.1 variant detected in North America and Europe

The PJ.2.1 variant of the coronavirus has been identified in Canada, the United States, and Europe. This strain is characterized by a high number of mutations in the spike protein, which is responsible for the virus entering human cells. Chinese researchers have referred to the variant as “The Leap” due to the significant number of changes compared to its predecessor strains.

Despite these mutations, scientists suggest that the variant is unlikely to trigger a new dangerous wave of infections. Albert Rezanov, head of the Center for Excellence in Personalized Medicine at Kazan Federal University, noted that an increase in mutations does not necessarily mean the virus has become more dangerous, more transmissible, or more severe. He explained that such variants often emerge in immunocompromised individuals where the infection persists for long periods, allowing the virus to adapt.

Research from German scientists indicates that while the PJ.2.1 variant shows significant differences from previous strains, it currently lacks a strong ability to evade immune responses. However, researchers warn that its ability to bind to receptors provides a margin that could allow for the rapid accumulation of new mutations, potentially enhancing its ability to bypass the immune system in the future.

Entities

Albert Rezanov · Kazan Federal University